Trial · NCT06381921
Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain
The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneou
- Status
- Recruiting
- Sponsor
- University of Connecticut
- Study type
- Interventional
- Phase
- No phase
- Enrollment
- 120 participants (planned)
- Start
- Sep 8, 2025
- Primary completion
- Oct 31, 2027
- Conditions
- Abdominal Pain
Summary
The objectives of the study are to 1) Conduct telemetric biosignals (EDA, ECG, and EMG) recording in healthy controls and IBS participants experiencing cutaneous and visceral pain; and 2) Validate the OIME index as a biomarker for quantifying pain in IBS participants and its capability to assess the treatment of IBS pain via an ambulatory trial.
Interventions
- IBS-PPSM intervention Behavioral
Locations
1 country: United States.
| Facility | City | Country |
|---|---|---|
| Vernon Cottage, Depot Campus | Storrs, Connecticut | United States |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.